Page 12 - Vaccine

Removing vaccination mandate for incoming tourists correct move: Experts

With over 90% of population being vaccinated, it is okay at a policy level to relax the mandatory vaccination norm for entering India, they say

BioNTech Q3 earnings drop but forecast for vaccine revenue grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, reported that its earnings in the third quarter were close to half what they were a year earlier, but the German pharmaceutical company still raised its expectations for vaccine revenue after rolling out updated shots targeting omicron strains. The company said Monday that it made net profit of 1.8 billion euros (USD 1.8 billion) off revenue of 3.5 billion euros (USD 3.5 billion) in the three months to September, a drop from profit of 3.2 billion euros and revenue of 6.1 billion euros in the same period a year ago. BioNTech said the course of the pandemic remains dynamic and led to fluctuations" in earnings. Profit and revenue were largely flat in the first nine months of the year. Thanks to our strong execution in the third quarter of 2022, we updated our COVID-19 vaccine revenue guidance for the year 2022 to the upper end of the original range," said Jens Holstein, CFO of BioNTech. We started shipments of o

Moderna misses Q3 expectations, net income dips 69%; defers vaccine sales

Sliding COVID-19 vaccine sales and rising expenses for Moderna combined to produce a third quarter that missed Wall Street expectations. The vaccine developer also said on Thursday that it was dialling back its revenue expectations from advance purchase agreements for this year, as some sales will be deferred to 2023. Moderna also said on Thursday that between USD 2 billion and USD 3 billion in vaccine sales will be deferred to next year, and the company now expects between USD 18 billion and USD 19 billion in revenue from advance purchase agreements this year. That's down from the approximately USD 21 billion it forecast in August. Company shares tumbled in early-morning trading. The vaccine developer said its Spikevax vaccine brought in USD 3.12 billion in sales during the quarter, a 35 per cent drop compared to last year. Moderna also scaled back expectations for COVID-19 vaccine deliveries in last year's third quarter due to supply issues. CEO Stephane Bancel said then that t

Pfizer, BioNTech start Covid-flu combination vaccine early-stage study

The single-dose vaccine candidate is a combination of Pfizer's mRNA-based flu shot and the companies' Omicron-tailored Covid-19 booster shot

Developing nations' vaccine manufacturers bat for pandemic treaty

It's time to focus on routine immunisation: Mandaviya

India's first Covid cure Vincov-19 completes second phase clinical trial

Completes phase 2 trials successfully on 200 patients

Indian Immunologicals to double foot and mouth disease vaccine capacity

To Invest Rs 700 crore in Hyderabad for new animal vaccine facility

How did India waste over 100 million Covid vaccines?

As memories of the Covid-19 horror started to ebb, a recent news shocked everyone. Over 100 million doses of Covid-19 vaccines were wasted last month. What led to this wastage? Let us find out

Canada's monkeypox tally at 1,406; 2nd vaccine dose to roll out this week

Canada has confirmed 1,406 cases of monkeypox, including 38 hospitalisations, the Public Health Agency of Canada said

Over 100 million Covid-19 vaccine doses wasted in India by September-end

Covid-19 vaccine makers have no plans to seek further shelf life extensions

Spike protein vaccines may help fight Covid variants: IIT-M study

Researchers sought to gauge the response in cases where post-vaccination infections were caused by a variant other than the original Wuhan strain

EU buys additional vaccine doses against monkeypox despite declining cases

The European Commission said it had secured over 10,000 tecovirimat vaccines against monkeypox, despite the declining number of cases in the European Union (EU)

What is Khosta-2? A vaccine-restraint virus found in Russian bats

It is classified as a sarbecovirus, a member of the Coronavirus family. It attaches to the same protein, ACE2 that Coronavirus uses to penetrate into human cells

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

ICAR signs tech transfer pact with Biovet for lumpy skin disease vaccine

India will need around 18-20 crore the indigenous lumpy vaccine doses to completely cover all the cattle population which is estimated to be around 193 million in a year

Nasal vaccines for Covid-19: How do they work and what are their benefits?

The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country

US added to WHO countries with circulating vaccine-derived poliovirus list

The US now joins a list of nearly 30 other countries with circulating vaccine-derived poliovirus (cVDPV) identified by the WHO, the US Centers for Disease Control and Prevention (CDC) said

Soon, India to get an adult TB vaccine

India is set to get an adult Tuberculosis vaccine soon. According to reports, SII is working on the rBCG vaccine. India reported a sharp 19 per cent rise in TB cases in 2021 over 2020. Watch the video to know more.

Centre, states working jointly to stop spread of Lumpy Skin Disease: PM

Says indigenous vaccine and movement of animals being stopped to control the spread of LSD

Top Headlines: Gyanvapi verdict today, Russia's discounted oil, and more

In a bid to counter the growing clamour among the G7 nations to enforce a price cap on Russian oil, Moscow told New Delhi it is willing to provide petroleum at even lower rates than before to India